Neurocrine Biosciences (NBIX)

Executive Summary

Neurocrine Biosciences, Inc., a commercial-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of neurological, endocrine, and psychiatric disorders in the United States. More Details


Trading at 57.4% below our estimate of its fair value

Earnings are forecast to grow 41.4% per year

Earnings grew by 339.6% over the past year

Risk Analysis

Has a high level of debt

Large one-off items impacting financial results

Snowflake Analysis

High growth potential with proven track record.

Similar Companies

Search for a company to compare.